KYNURENINE HYDROXYLASE - A POTENTIAL RATE-LIMITING ENZYME IN TRYPTOPHAN-METABOLISM
KYNURENINE HYDROXYLASE - A POTENTIAL RATE-LIMITING ENZYME IN TRYPTOPHAN-METABOLISM
复制标题
DOI:
10.1042/bst0130441
复制
发表时间:
1985-01-01
影响因子:
3.9
通讯作者:
MCCREANOR, GM
中科院分区:
文献类型:
--
作者:
BENDER, DA;MCCREANOR, GM
Kynurenine hydroxylase activity is markedly reduced in hyperthyroidism. The administration of thyroxine to rats results in a fall to 50% of the control activity over several days. This is reflected in a change in the K/HK ratio from 2.6 to 22.2. On withdrawal of the hormone there is a gradual recovery of the enzyme, and a return to the control K/HK ratio. This inhibition of tryptophan oxidative metabolism results in a significant reduction in the synthesis de nouo of nicotinamide nucleotides and a reduction in tissue concentrations of the coenzymes (Okamoto et al., 1971). A dietary excess of leucine has been implicated in the aetiology of the niacin-deficiency disease, pellagra (Gopalan & Srikantia, 1960). Magboul & Bender (1983) have confirmed that a relative excess of leucine in the diet inhibits the synthesis of NAD (P) from tryptophan in rats. A number of factors may be involved, including: competition between kynurenine and tryptophan for uptake into tissues; increased activity of picolinate carboxylase (Bender, 1983) and inhibition of kynureninase by leucine and of kynurenine hydroxylase by a-oxoisocaproate, the 0x0 acid of leucine (Magbod& Bender, 1983). This last is unlikely to be physiologically important. The inhibition of kynurenine hydroxylase by a-oxoisocaproate is mainly non-competitive, with a K, of 63 k 1 8 m~(DA Bender, unpublished work), while tissue concentrations of a-oxoisocaproate do not normally rise above 5-1Op~(Hutson & Harper, 1981). Even feeding a high-leucine diet is unlikely to cause a sufficient accumulation of a-oxoisocaproate to give significant inhibition of kynurenine hydroxylase. A number of studies have shown that the incidence of pellagra is twice as high in women as in men (Miller, 1978). An important factor may be inhibition of kynureninase by oestrogen metabolites (Bender & Wynick, 198 1). Additionally, Bender & Totoe (1984) have shown that in ovariectomized rats receiving oestrone sulphate (1 5 mg/kg of diet, approximately equivalent to doses used in menopausal hormone replacement therapy), the activity of kynurenine hydroxylase in the liver is reduced to 30% of that in control animals. Under these conditions, the activity of kynurenine hydroxylase is certainly lower than that of any other enzyme of tryptophan oxidative metabolism; oestrogen-treated rats have lower tissue concentrations of nicotinamide nucleotides and lower excretion of NL-methylnicotinamide, the end product of NAD (P) metabolism. The mechanism of this action of oestrogens is not clear. The addition of up to 1 mwoestrone sulphate, oestradiol or ethynyloestradiol in vitro has no effect on the activity of the hydroxylase, yet changes in hydroxylase activity are apparent within 12 h of the intraperitoneal injection of ethynyloestradiol into ovariectomized rats (DA Bender & J.-F. Bowden, unpublished work).Endogenous oestrogens may also affect kynurenine hydroxylase. El-Zoghby at al.(1978a) showed that the spontaneous excretion of K/HK was 0.5 in pre-pubertal girls, while in women aged between 23 and 40 years the ratio was 4.7, and in post-menopausal women it was 1.4. The activity of tryptophan oxygenase is the limiting factor for the entry of tryptophan into the pathway that leads to irreversible oxidative catabolism, and the removal of tryptophan from the body. Nevertheless, it is likely that when the flux of metabolites through the oxidative pathway is increased, as after induction of tryptophan oxygenase by corticosteroid hormones or the administration of a loading dose of tryptophan, or when kynurenine hydroxylase is moderately inhibited, the hydroxylation of kynurenine becomes rate-limiting for the onward metabolism of tryptophan metabolites to …